BPC-157 Frequently Asked Questions (Research Use Only) This FAQ provides structured, research-focused information about BPC-157, a synthetic peptide supplied as a lyophilized powder for controlled laboratory environments
And while more studies can never hurt, existing evidence suggests the risk is very low
Reconstitution Steps Gather your supplies BPC-157 vial, bacteriostatic water, alcohol swabs, and an insulin syringe (1mL / 100 unit)
The concentration choice for a 12-mg-weekly patient on a 30 mg vial usually lands at 15 mg/mL or 20 mg/mL
Communication before and after purchase was satisfactory
For your clinic, this impacts: Your service menu Treatment descriptions Consent forms Marketing materials If you say a treatment is "FDA-approved" when it isn't, or hint at benefits the data doesn't back, you risk regulatory trouble